Trans-sodium crocetinate does not affect oxygen uptake in rats during treadmill running

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 7, 2005, Pages 577-584

  Kemi, O J ^a,c   Ellingsen, O ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Exercise; TSC

Indexed keywords

CROCETIN; OXYGEN; PLACEBO; SODIUM CROCETINATE; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; ANIMAL EXPERIMENT; ARTICLE; BLEEDING; BLOOD PRESSURE; CONTROLLED STUDY; EXHAUSTION; HEART RATE; HEMORRHAGIC SHOCK; INJECTION; ISOMER; MALE; MUSCLE MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TRANSPORT; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STEADY STATE; SURVIVAL; TREADMILL EXERCISE; VELOCITY; VENOUS OXYGEN TENSION;

ANIMALIA;

EID: 31544478014     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00291950500228121     Document Type: Article

References (15)

1. Laidig KE, Gainer JL, Daggett V. Altering diffusivity in biological solutions through modification of solution structure and dynamics. J Am Chem Soc 1998;120:9394-5.
2. Giassi LJ, Gilchrist MJ, Graham MC, Gainer JL. Trans-sodium crocetinate restores blood pressure, heart rate and plasma lactate after hemorrhagic shock. J Trauma 2001;51:932-8.
3. Giassi LJ, Poynter AK, Gainer LJ. Trans-sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy. Shock 2002;18:585-8.
4. Roy JW, Graham MC, Griffin AM, Gainer JL. A novel fluid replacement therapy for hemorrhagic shock. Shock 1998;10:213-7.
5. Singer M, Stidwill RP, Nathan A, Gainer JL. Intravenous crocetinate prolongs survival in a rat model of lethal hypoxemia. Crit Care Med 2000;28:1968-72.
6. Okonkwo DO, Wagner J, Melon DE, Alden T, Stone RR, Helm GA, et al. Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation. Neurosci Lett 2003;352:97-100.
7. 2max at sea level and altitude. Respir Physiol 1996;106:329-43.
8. Wisløff U, Helgerud J, Kemi OJ, Ellingsen Ø. Intensity-controlled treadmill running in rats: VO2max and cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2001;280:H1301-10.
9. Wagner PD, Hsia CCW, Goel R, Fay JM, Wagner HE, Johnson RL, Jr. Effects of crocetin on pulmonary gas exchange in foxhounds during hypoxic exercise. J Appl Physiol 2000;89:235-41.
10. Taylor CR, Maloiy GM, Weibel ER, Langman VA, Kamau JM, Seeherman HJ, et al. Design of the mammalian respiratory system. III. Scaling maximum aerobic capacity to body mass: wild and domestic mammals. Respir Physiol 1981;44:25-37.
11. Darveau CA, Suarez RK, Andrews RD, Hochachka PW. Allometric cascade as a unifying principle of body mass effects on metabolism. Nature 2002;417:166-70.
12. Pate RR, Kriska A. Physiological basis of the sex difference in cardiorespiratory endurance. Sports Med 1984;1:87-98.
13. 2max in moderate hypoxia. Respir Physiol Neurobiol 2003;134:239-46.
14. Kemi OJ, Haram PM, Wisløff U, Ellingsen Ø. Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 2004;109:2897-904.
15. Kemi OJ, Loennechen JP, Wisløff U, Ellingsen Ø. Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol 2002;93:1301-9.